Skip to main content
Premium Trial:

Request an Annual Quote

Qselect, NanoManipulator DP-100.


Genetix of Hampshire, UK, has introduced Qselect, an automated robotic system for managing and developing genomic and cDNA libraries.

Qselect is designed to screen the libraries, then replicate designated samples. The system can be used with 420-, 96-, or 384-wellplates.

“Until now, people would do this manually, with handheld pin devices,” said Susan Richards, worldwide sales and marketing manager for Genetix. “This allows you to make rapid replicas.”

In addition to Qselect, Richards said Genetix was gearing up for the launch of a new microarrayer, which will have high slide and plate capacity but will be compact enough to fit in a small laboratory.

The new microarrayer, which will use a spotting device to make oligo and/or cDNA microarrays, is expected to sell for $25,000.

3rdTech of Chapel Hill, NC, is planning to ship its NanoManipulator DP-100 visualization and control system, a nanotechnology device that enables users to view and manipulate nanoscale objects in 3D. The system is designed for R&D in nano-electro mechanical systems, genomics, material science, biochemistry, and physics.

The NanoManipulator consists of a SensAble Technologies Phantom Desktop force-feedback device, a PC with 3D graphics, and NanoManipulator DP-100 software. The system operates on a scanning probe microscope (SPM) from ThermoMicroscopes.

The system, which was developed with technology from the departments of computer science and physics and astronomy at the University of North Carolina at Chapel Hill with funding from the National Institutes of Health Center for Research Resources, sells for $85,000 and includes on-site installation and training.

The NanoManipulator System is ready to ship immediately, the company said.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.